Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care

Journal of Pharmacy Practice
Jordan L SchultzLisa A Mascardo

Abstract

This study analyzed the impact of a pharmacist-managed diabetes clinic on clinical outcomes compared to usual care received from primary care providers (PCPs). This comparison may more definitively demonstrate the value of pharmacist management of chronic disease states. Retrospective observational cohort study conducted in patients referred to a pharmacist-managed pharmacotherapy (PT) clinic from July 2009 to October 2014. For the primary outcome, the absolute change in A1c during the usual care phase was +1.53% (95% confidence interval [CI]: 1.10-1.96, P < .0001) versus an absolute change of -1.63% (95% CI: -1.28 to -1.97, P < .0001) in the intervention phase. For secondary outcomes, diabetes-related hospitalizations (10 vs 6, P = .104) and emergency room (ER) visits (27 vs 8, P = .049) decreased in the intervention phase compared to the usual care phase. The rate of diabetes-related interventions made per patient per year in the usual care phase was 2.7 versus 11.1 in the intervention phase ( P < .0001). Patients referred to the PT clinic had worsening blood glucose control prior to referral, and their control improved after referral to the clinic. Furthermore, there was an improvement in all diabetes-related outcomes in the...Continue Reading

References

Jan 15, 2008·Journal of the American Pharmacists Association : JAPhA·Barry A BuntingSusan E Sutherland
Mar 25, 2008·Journal of the American Pharmacists Association : JAPhA·Brian J IsettsRobert J Cipolle
May 4, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Eric J IpDeempal C Bhatt
Mar 26, 2016·Journal of Managed Care & Specialty Pharmacy·John J KoPaul J Godley

❮ Previous
Next ❯

Citations

Mar 16, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Safiya S NaidjateChristine Berard-Collins
Jul 25, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Shane P DesselleDavid P Zgarrick
Jul 15, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Jarred Prudencio, Michelle Kim
Dec 16, 2020·Journal of Pharmacy Practice·Karl HessSheila M Seed
Feb 12, 2021·Journal of Clinical Pharmacy and Therapeutics·Shang-En WuElizabeth H Chang
Jan 25, 2021·Journal of the American Pharmacists Association : JAPhA·Christine Chim, Victoria Joseph
Apr 13, 2021·Journal of Pharmacy Practice·Elizabeth M BaldKorey Kennelty
Sep 3, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Evan K Perrault, Jenny L Beal

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.